Apixaban Has Lower Bleeding Risk for Initial Anticoagulation for Venous Thromboembolism
During extended treatment, bleeding risk was similar for apixaban and rivaroxaban
Diagnosis & Disease Information
Prolonged Direct Oral Anticoagulants Beneficial for Preventing Recurrent VTE
Findings seen among adults prescribed warfarin, DOACs beyond 6 months after acute venous thromboembolism
Cardiovascular Event Risk Elevated Before ANCA-Associated Vasculitis Diagnosis
New findings reported by Danish investigators are from the first study to demonstrate the association.
Cannabis Use Disorder Linked to Perioperative Complications
Increase seen in in-hospital mortality and 7 perioperative complications for adults undergoing major elective inpatient surgery
Anticoagulants Do Not Reduce Arterial Thrombotic Event Risk in Cancer
No reduction seen in risk of thrombotic events but increased risk of major and minor bleeding
Benefits of Indefinite Anticoagulant Unclear After First VTE
Indefinite anticoagulation prevented recurrent VTE events, but induced major bleeding events
Catheter-Directed Thrombolysis Beneficial for Pulmonary Embolism
Systematic review showed risk for death and major bleeding complications was lower for catheter-directed thrombolysis than systemic thrombolysis
Direct Oral Anticoagulant Therapy Feasible for Cancer Patients
Direct oral anticoagulants noninferior to low-molecular-weight heparin for venous thromboembolism prevention
Higher Likelihood of Excellent Outcome After Stroke Seen With Tirofiban
Findings seen in patients with ischemic stroke without occlusion of large or medium-sized vessels, at least one moderately to severely weak limb
Risk Factors for Venous Thromboembolism in Kidney Transplant Recipients Identified
Venous thromboembolism occurred in the graft in 15.4% of patients.
- Loading...
Loading...
Next post in American Transplant Congress
Loading... 
Loading...